文献速递类风湿关节炎

抗氨甲酰化纤维蛋白原IgG和IgA抗体有助于极早期类风湿关节炎更好的预后分层:法国ESPOIR队列数据

Anti-Carbamylated Fibrinogen Autoantibodies of IgG and IgA Isotypes Contribute to a Better Prognostic Stratification in Very Early Rheumatoid Arthritis: Data From the French National ESPOIR Cohort.
PubMed 文献 · Arthritis Rheumatol · 2026-07-27

该研究在法国ESPOIR队列619例患者(含575例RA)中,于基线及6、24个月定量检测ACa-Fib IgG和IgA,评估其诊断和预后价值。结果显示ACa-Fib IgG和IgA在抗CCP阴性RA中分别检出16.6%和6.3%,ACa-Fib IgG最高四分位(≥20.29 AU)与快速影像学进展风险增加相关,ACa-Fib IgA(≥3.07 AU)亦与结构进展相关(OR 1.9,95%CI 1.1-3.4,P=0.031)。

要点

  • ACa-Fib IgG和IgA可在抗CCP阴性早期RA中检出,提供额外血清学信息。
  • ACa-Fib IgG最高四分位(≥20.29 AU)与快速影像学进展风险增加相关。
  • ACa-Fib IgA(≥3.07 AU)与结构进展相关(OR 1.9,95%CI 1.1-3.4,P=0.031)。

核心结论

  • ACa-Fib IgG和IgA具有不同的纵向变化和预后关联,可作为早期RA风险分层的补充生物标志物。

研究设计与样本

  • 基于法国ESPOIR队列,纳入619例符合2010年ACR/EULAR分类标准的患者(含575例RA),基线及6、24个月用自制ELISA定量ACa-Fib IgG和IgA,并收集临床、生物学和影像学数据。

主要发现

  • 基线时ACa-Fib IgG和IgA在抗CCP阴性RA中的检出率分别为16.6%和6.3%。
  • 基线ACa-Fib水平与治疗反应或缓解无关。
  • 24个月内ACa-Fib IgG水平下降,而IgA水平保持稳定。
  • 较高的ACa-Fib IgA水平与更长的吸烟 duration(P=0.003)和累积吸烟暴露(P=0.016)相关。
  • ACa-Fib IgG最高四分位(≥20.29 AU)与快速影像学进展风险增加相关(全局P=0.004);ACa-Fib IgA(≥3.07 AU)与结构进展相关(OR 1.9,95%CI 1.1-3.4,P=0.031)。

关键数值与推荐

  • ACa-Fib IgG最高四分位阈值≥20.29 arbitrary units(AU),与快速影像学进展风险增加相关(全局P=0.004)。
  • ACa-Fib IgA阈值≥3.07 AU,与结构进展相关(OR 1.9,95%CI 1.1-3.4,P=0.031)。

临床怎么用

  • 在早期RA尤其是抗CCP阴性患者中,可考虑检测ACa-Fib IgG和IgA以辅助预后分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the prevalence and longitudinal evolution of anti-carbamylated fibrinogen antibodies (ACa-Fib) of IgG and IgA isotypes in early rheumatoid arthritis (RA) and determine whether these antibodies provide additional diagnostic and prognostic information beyond anti-cyclic citrullinated peptide (anti-CCP) antibodies and rheumatoid factors. METHODS: ACa-Fib IgG and IgA were quantified by in-house enzyme-linked immunosorbent assay at baseline and 6 and 24 months in 619 patients with available 2010 American College of Rheumatology/EULAR classification criteria, including 575 patients with RA, from the French ESPOIR cohort. Clinical, biologic, and radiographic data were collected. Multivariable models and appropriate statistical analyses were used to assess associations between ACa-Fib levels and disease activity, therapeutic response, smoking exposure, C-reactive protein concentrations, and structural progression. RESULTS: At baseline, ACa-Fib IgG and IgA were detected in 16.6% and 6.3% of patients with anti-CCP-negative RA, respectively. Baseline ACa-Fib levels were not associated with therapeutic response or remission. Over 24 months, ACa-Fib IgG levels decreased, whereas IgA levels remained stable. Higher ACa-Fib IgA levels were associated with longer smoking duration (P = 0.003) and cumulative smoking exposure (P = 0.016). Patients in the highest quartile of ACa-Fib IgG (≥20.29 arbitrary units [AU]) had an increased risk of rapid radiographic progression (global P = 0.004). Despite its markedly lower prevalence, ACa-Fib IgA (≥3.07 AU) was also associated with structural progression (odds ratio 1.9, 95% confidence interval 1.1-3.4, P = 0.031). CONCLUSION: The distinct longitudinal behavior and prognostic associations of ACa-Fib IgG and IgA highlight a previously underappreciated component of the anti-carbamylated protein response and support their utility as complementary biomarkers for improved risk stratification in early RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Brevet P, Guérin O, Le Goaréguer L, et al. Anti-Carbamylated Fibrinogen Autoantibodies of IgG and IgA Isotypes Contribute to a Better Prognostic Stratification in Very Early Rheumatoid Arthritis: Data From the French National ESPOIR Cohort. Arthritis Rheumatol. 2026. PMID: 42504150. doi:10.1002/art.70281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。